Overview


According to FutureWise analysis the market for Disposable Point-Of-Care Testing (POCT) Devices is expected to reach US$ 38.84 billion by 2031 at a CAGR of 6.60%.

A sort of medical diagnostic testing is point-of-care testing, often known as bedside testing. Point-of-care testing equipment are used to obtain diagnostic results that are close to or in the presence of the patient. Disposable POCT devices are those that cannot be used again once they have been used. POCT stands for point of care test, which is a diagnostic test performed using both electronic and non-electronic instruments. It eliminates the need for many laboratory and clinical investigations, reducing test turnaround time. The rise in demand for POCT among patients, increased disposable income, and rapid expansion in medical tourism in Europe are the primary factors driving market growth. The market's expansion is hampered by a lack of understanding about POC tests. Furthermore, increasing technical advancements in the field of POC tests would provide significant market growth possibilities. The rising prevalence of chronic diseases such as diabetes, cancer, and infectious diseases around the world is one of the key factors projected to fuel the growth and demand for disposable point-of-care testing (POCT) equipment. Furthermore, the rising incidence of elderly population around the world, as well as the increased requirement for quick screening for diseases including influenza, dengue, HIV, and malaria, are likely to drive worldwide market growth over the forecast period. The rising prevalence of the condition, as well as the ease with which blood glucose levels may be measured using a glucose monitoring device, are expected to boost market growth. Furthermore, rising public awareness of point-of-care testing devices and increased product approvals are likely to fuel the expansion of the disposable point-of-care testing (POCT) devices market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Disposable Point-Of-Care Testing (POCT) Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Disposable Point-Of-Care Testing (POCT) Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Danaher
  • Abbott
  • F. OraSure Technologies, Inc..
  • BD
  • Trinity Biotech Ireland
  • Cardinal Health
  • Thermo Fisher Scientific
  • Chembio Diagnostics, Inc.
  • Meridian Bioscience
  • Sekisui Diagnostics
  • OraSure Technologies, Inc.
  • Quidel Corporation
  • Siemens Healthcare Private Limited
  • Nova Biomedical
  • EKF Diagnostics
  • Beckman Coulter, Inc.
  • Bayer AG
  • bioMerieux SA
  • Johnson & Johnson Services, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Glucose Monitoring Devices
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Pregnancy and Fertility Testing Products
  • Hematology Testing Products
  • Drugs-of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Cholesterol Testing Products
  • Others

By Technology

  • Dipsticks
  • Lateral Flow Assays
  • Molecular Diagnostics
  • Microfluidics
  • Immunoassays
  • Others

By Prescription Mode

  • Prescription-Based
  • OTC

By End User

  • Hospitals
  • clinics
  • Homecare
  • Research Laboratories
  • Ambulatory Care Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Disposable Point-Of-Care Testing (POCT) Devices Market By Product, By Technology, By Prescription Mode, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Disposable Point-Of-Care Testing (POCT) Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Disposable Point-Of-Care Testing (POCT) Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Disposable Point-Of-Care Testing (POCT) Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Disposable Point-Of-Care Testing (POCT) Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Glucose Monitoring Devices
        2. Cardiometabolic Monitoring Products
        3. Infectious Disease Testing Products
        4. Coagulation Monitoring Products
        5. Pregnancy and Fertility Testing Products
        6. Hematology Testing Products
        7. Drugs-of-Abuse Testing Products
        8. Fecal Occult Testing Products
        9. Cholesterol Testing Products
        10.Others

  • 8.   Disposable Point-Of-Care Testing (POCT) Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dipsticks
        2. Lateral Flow Assays
        3. Molecular Diagnostics
        4. Microfluidics
        5. Immunoassays
        6. Others

  • 9.   Disposable Point-Of-Care Testing (POCT) Devices Market, By Prescription Mode Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prescription-Based
        2. OTC

  • 10.   Disposable Point-Of-Care Testing (POCT) Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Homecare
        4. Research Laboratories
        5. Ambulatory Care Centers
        6. Others

  • 11.   North America Disposable Point-Of-Care Testing (POCT) Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Disposable Point-Of-Care Testing (POCT) Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Disposable Point-Of-Care Testing (POCT) Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Disposable Point-Of-Care Testing (POCT) Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Danaher
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. F. OraSure Technologies, Inc..
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. BD
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Trinity Biotech Ireland
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cardinal Health
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Thermo Fisher Scientific
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Chembio Diagnostics, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Meridian Bioscience
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Sekisui Diagnostics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.OraSure Technologies, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Quidel Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Siemens Healthcare Private Limited
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Nova Biomedical
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.EKF Diagnostics
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Beckman Coulter, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.Bayer AG
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.bioMerieux SA
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.Johnson & Johnson Services, Inc.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    • 1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients